Geron | GERN - Gross Profit On Sales

Stock Price
1.71
Daily Change
0.06 3.39%
Monthly
28.27%
Yearly
-3.07%
Q1 Forecast
1.82

Geron reported $46.71M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Amgen USD 6.48B 307M Sep/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Cytokinetics USD 17.76M 15.82M Dec/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Exelixis USD 572.18M 7M Dec/2025
Genmab DKK 868M 195M Jun/2025
Geron USD 46.71M 525K Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
MacroGenics USD 61.25M 88.71M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Novavax USD 23.89M 239.21M Sep/2024